Company / Operating Cash Flow
OptimizeRx Corp Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$4.9M
FY2025
5-year range
-$7.2M / $10.7M
FY2021-FY2025
Trend
+167.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$7M in FY2024 to $11M in FY2023.
Based on SEC 10-K filings.
$5M in FY2025 with a 3-year CAGR of +88.8%.
Declined from $11M to $5M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +88.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +88.8%, indicating consistent growth.
- In FY2025, operating cash flow increased 167.5% year-over-year.
- Peak operating cash flow was recorded in FY2023.
- Lowest operating cash flow in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.9M | +167.5% |
| FY2024 | -$7.2M | -168.0% |
| FY2023 | $10.7M | +1367.4% |
| FY2022 | $726.0K | +111.5% |
| FY2021 | -$6.3M | -280.0% |
| FY2020 | -$1.7M | -309.5% |
| FY2019 | $792.6K | +153.6% |
| FY2018 | -$1.5M | -217.6% |
| FY2017 | -$466.0K | -190.5% |
| FY2016 | $515.1K | +1014.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026